Incyte to Report First Quarter Financial Results
Incyte (NASDAQ:INCY) has announced its conference call and webcast scheduled for May 2, 2023, at 8:00 a.m. ET to discuss its Q1 2023 financial results. The press release for these results will be available earlier that day at 7:00 a.m. ET. Investors can access the call via domestic and international dial-in numbers or through an online webcast at Investor.Incyte.com. A replay of the conference call will be accessible for 30 days following the event. Incyte is a global biopharmaceutical company headquartered in Wilmington, Delaware, dedicated to addressing serious unmet medical needs through the development of innovative therapeutics.
- None.
- None.
- The schedule for the press release and conference call/webcast is as follows:
-
Q1 2023 Press Release:
May 2, 2023 at7:00 a.m. ET -
Q1 2023 Conference Call:
May 2, 2023 at8:00 a.m. ET - Domestic Dial-In Number: 877-407-3042
- International Dial-In Number: 201-389-0864
- Conference ID Number: 13737924
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the
The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for ninety days.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20230411005060/en/
Media
+1 302 498 6171
cloveman@incyte.com
Investors
+1 302 274 4773
cchiou@incyte.com
Source:
FAQ
When will Incyte announce its Q1 2023 financial results?
What time is the Incyte Q1 2023 conference call?
How can I access the Incyte conference call?